Detalhe da pesquisa
1.
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
Eur J Neurol
; 31(6): e16250, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38549186
2.
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180219
3.
Obesity worsens central inflammation and disability in multiple sclerosis.
Mult Scler
; 26(10): 1237-1246, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161863
4.
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection.
Mult Scler Relat Disord
; 57: 103345, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158454
5.
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients.
Neurotherapeutics
; 18(4): 2598-2607, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34494237